Legal Representation
Attorney
Cheryl L. Foytlin
USPTO Deadlines
Application History
33 events| Date | Code | Type | Description |
|---|---|---|---|
| Mar 23, 2020 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Mar 23, 2020 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Mar 18, 2020 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Jul 6, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jul 5, 2019 | EX5G | S | SOU EXTENSION 5 GRANTED |
| Jul 3, 2019 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Jun 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jun 28, 2019 | EXT5 | S | SOU EXTENSION 5 FILED |
| Jun 12, 2019 | DOCK | D | ASSIGNED TO EXAMINER |
| Jan 17, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 15, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 15, 2019 | EXT4 | S | SOU EXTENSION 4 FILED |
| Jan 15, 2019 | EX4G | S | SOU EXTENSION 4 GRANTED |
| Aug 15, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 13, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 13, 2018 | EXT3 | S | SOU EXTENSION 3 FILED |
| Aug 13, 2018 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Jan 26, 2018 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jan 24, 2018 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Jan 24, 2018 | EXT2 | S | SOU EXTENSION 2 FILED |
| Jan 24, 2018 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Aug 9, 2017 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Aug 7, 2017 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Aug 7, 2017 | EXT1 | S | SOU EXTENSION 1 FILED |
| Aug 7, 2017 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Feb 21, 2017 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Dec 27, 2016 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Dec 27, 2016 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Dec 7, 2016 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Nov 21, 2016 | DOCK | D | ASSIGNED TO EXAMINER |
| Nov 21, 2016 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 22, 2016 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Aug 20, 2016 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, and respiratory diseases; vaccines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005